Rodent models are commonly used for evaluating therapeutics prior to clinical studies. MD Biosciences offers a range of in vivo efficacy models for the study of pain, neurodegeneration, neuroinflammation and wound healing. We integrate behavior assessments and cutting-edge biomarkers that provide crucial insights for the advancement of your program.
Ready to discuss your project?
If you are ready to discuss your development program, our scientists are eager to explore the possibilities with you. Like many other pharmaceutical and medical device developers, you can benefit from partnering with a preclinical CRO focused on translational outcomes in pain and neurodegenerative diseases.